What are the causes of a falsely elevated fecal calprotectin level greater than 800 µg/g?

Causes of Falsely Elevated Fecal Calprotectin >800 µg/g

A fecal calprotectin >800 µg/g is rarely "falsely" elevated in the traditional sense—this level typically indicates genuine intestinal inflammation, though the inflammation may not be from inflammatory bowel disease (IBD). However, several non-IBD conditions and medications can cause truly elevated levels that might be considered "false positives" if you're specifically looking for IBD.

Medication-Related Causes

NSAIDs and PPIs are the most common culprits for medication-induced elevation:

• NSAIDs cause direct mucosal injury and neutrophil infiltration, leading to significantly elevated fecal calprotectin levels (median 57 vs 25 μg/g in non-users, though levels >800 are possible with active NSAID-induced enteropathy) 12
• Proton pump inhibitors (PPIs) are associated with elevated levels (median 66 vs 23 μg/g in non-users), with a negative correlation between time since PPI prescription and fecal calprotectin levels 1
• The effect is dose-dependent and time-dependent—recent use (within 90 days) shows stronger associations 1

Critical pitfall: Always obtain medication history before interpreting fecal calprotectin, as these medications can lead to unnecessary colonoscopies and treatment escalations 1.

Non-IBD Gastrointestinal Pathology

While levels >800 µg/g are less common in these conditions, they can occur:

• Upper GI disease (gastritis, peptic ulcer disease) can elevate fecal calprotectin, though typically to lower levels 3
• Infectious gastroenteritis causes genuine neutrophilic inflammation and can produce very high levels 4
• Microscopic colitis may be missed on standard colonoscopy if biopsies aren't taken 5
• Small bowel pathology not visible on colonoscopy (requires capsule endoscopy or MR enterography) 5

Systemic and Extra-Intestinal Causes

• Liver cirrhosis is associated with false-positive results 2
• Aspirin use (distinct from NSAIDs) 2

Pre-Analytical and Technical Factors

• Improper sample collection or storage (though this typically causes falsely low, not high, values)
• Assay variability between different manufacturers, though standardization has improved 4

Clinical Approach to Fecal Calprotectin >800 µg/g

When you encounter a level >800 µg/g:

1. First, verify medication exposure: Stop NSAIDs/PPIs if possible and retest in 4-6 weeks before proceeding with invasive testing 1

2. If medications excluded and patient symptomatic: Proceed directly to colonoscopy with ileoscopy, as levels >250 µg/g have high specificity (73%) for endoscopic inflammation in symptomatic patients 66

3. If colonoscopy is normal: Consider:

   • Small bowel imaging (MR enterography or capsule endoscopy) for isolated small bowel Crohn's disease 5
   • Upper endoscopy with biopsies for gastric/duodenal pathology 3
   • Stool cultures if infectious etiology suspected 4
   • Random colonic biopsies for microscopic colitis if not already obtained

4. If all investigations normal: Repeat fecal calprotectin in 3-6 months, as the negative predictive value for significant pathology with mildly elevated levels is high (97.5% for significant luminal pathology), though your level of >800 demands more thorough investigation 7

The key distinction: Levels >800 µg/g are almost never "false positives" in the sense of laboratory error—they represent real neutrophilic inflammation. The question is whether that inflammation is from IBD or another cause. The AGA guidelines emphasize that elevated fecal calprotectin >150-250 µg/g in symptomatic patients warrants endoscopic assessment rather than empiric treatment 866, and levels >800 µg/g make this recommendation even stronger.